BTG3 and systemic lupus erythematosus: In general, the disease severity of SLE is accessed by evaluating symptoms that partly attributed to characteristic clinical findings in the skin, joints, kidneys, and central nervous system, as well as serological parameters such as ANA, cytokine, and immune complex deposition [3].